Search - tctmd.com

Displaying 61 - 80 of 147

Sort: Relevancy | Date

Presentation TCT 2022

TCT 324: Cerebral Embolic Protection Devices and Outcomes of Transcatheter Aortic Valve Replacement: Insight from National Readmission Database 2017-2019.

Presenter: Ahmed Altibi

September 17, 2022

Presentation TCT 2022

Cerebral Embolic Protection: Why, When, and Who?

Presenter: Axel Linke

September 17, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

Presentation TCT 2021

TCT 51: Complete Cerebral Protection via Left Radial Approach during Transcatheter Aortic Valve Replacement – Results from the PROTEMBO C Trial

Presenter: Tobias Schmidt

November 05, 2021

Presentation TCT 2021

Captis: Full-Body Embolic Protection Device

Presenter: Haim Danenberg

November 04, 2021

Presentation TCT 2021

Cerebral Protection in TAVR: The PROTEMBO C Trial

Presenter: Tobias Schmidt

November 04, 2021

Presentation TCT 2021

LAA Closure with the Laminar Device: technology and Clinical Update

Presenter: Jason H. Rogers

November 04, 2021

World’s First Dedicated 3D Sizing LAA Exclusion Device (Paladin Medical’s Trinity System)

Presentation TCT 2021

Introducing XCLUDE Integrated Solution. World's First Dedicated LAA 3D Sizing Device and Next-Gen LAA Exclusion Device

Presenter: Flavio Airoldi

November 04, 2021

Presentation TCT 2021

Next Generation LAA Exclusion System to Reduce Stroke Risk in AF Patients (Append)

Presenter: Zachi Berger

November 04, 2021

Presentation TCT 2021

Featured Lecture: Clinical Outcomes of LAAO versus NOACS in Atrial Fibrillation in Patients with Prior Ischemic Stroke: Is There Room for Improvement in Clinical Outcomes?

Presenter: Jens Erik Nielsen-Kudsk

November 04, 2021

Presentation TCT 2021

TCT 709: Protected TAVR with self-expandable Meril MyVal THV using ProtEmbo for intra-aortic cerebral protection

Presenter: Dariusz Jagielak

November 04, 2021

Presentation TCT 2020

Cerebral Embolic Protection and TAVR Outcomes: Results from the TVT Registry

Presenter: David Cohen

October 16, 2020

News Conference News TCT 2020

Large Databases Hint at Sentinel Benefit During TAVR, but Uncertainty Remains

Todd Neale

October 16, 2020

Presentation TCT 2020

TCT ID 6: Ischemic Stroke With Cerebral Protection System During Transcatheter Aortic Valve Replacement

Presenter: Michael Megaly

October 15, 2020

Presentation TCT 2020

A Randomized Evaluation oF the TriGUARD3™ Cerebral Embolic Protection Device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation The REFLECT II Trial

Presenter: Jeffrey W. Moses

October 15, 2020

News Conference News TCT 2020

Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II

Todd Neale

October 15, 2020

Presentation TCT 2020

TCT 635: Left Atrial Appendage Closure With Thrombus and Cerebral Protection Device

Presenter: Berenice Caneiro-Queija

October 14, 2020

Presentation TCT 2020

TCT 510: Contrast-free LVAD Outflow Intervention With Cerebral Protection

Presenter: Joshua Vogt

October 14, 2020

Presentation TCT 2020

TCT 463: Computed Tomography Angiography-Fluoroscopy Fusion Imaging for the Guidance of Cerebral Embolic Protection Deployment During Transcatheter Aortic Valve Replacement

Presenter: Craig Basman

October 14, 2020

Presentation TCT 2020

TCT 484: Inclusion of Very Small Cerebral Lesions in Quantitative Embolic Protection Study Endpoints May Obscure Clinical Relevance

Presenter: Michael Dwyer

October 14, 2020

Advertisement

TCT 324: Cerebral Embolic Protection Devices and Outcomes of Transcatheter Aortic Valve Replacement: Insight from National Readmission Database 2017-2019.

Cerebral Embolic Protection: Why, When, and Who?

New Faces, New Formats, New Tech: What to Expect From TCT 2022

TCT 51: Complete Cerebral Protection via Left Radial Approach during Transcatheter Aortic Valve Replacement – Results from the PROTEMBO C Trial

Captis: Full-Body Embolic Protection Device

Cerebral Protection in TAVR: The PROTEMBO C Trial

LAA Closure with the Laminar Device: technology and Clinical Update

Introducing XCLUDE Integrated Solution. World's First Dedicated LAA 3D Sizing Device and Next-Gen LAA Exclusion Device

Next Generation LAA Exclusion System to Reduce Stroke Risk in AF Patients (Append)

Featured Lecture: Clinical Outcomes of LAAO versus NOACS in Atrial Fibrillation in Patients with Prior Ischemic Stroke: Is There Room for Improvement in Clinical Outcomes?

TCT 709: Protected TAVR with self-expandable Meril MyVal THV using ProtEmbo for intra-aortic cerebral protection

Cerebral Embolic Protection and TAVR Outcomes: Results from the TVT Registry

Large Databases Hint at Sentinel Benefit During TAVR, but Uncertainty Remains

TCT ID 6: Ischemic Stroke With Cerebral Protection System During Transcatheter Aortic Valve Replacement

A Randomized Evaluation oF the TriGUARD3™ Cerebral Embolic Protection Device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation The REFLECT II Trial

Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II

TCT 635: Left Atrial Appendage Closure With Thrombus and Cerebral Protection Device

TCT 510: Contrast-free LVAD Outflow Intervention With Cerebral Protection

TCT 463: Computed Tomography Angiography-Fluoroscopy Fusion Imaging for the Guidance of Cerebral Embolic Protection Deployment During Transcatheter Aortic Valve Replacement

TCT 484: Inclusion of Very Small Cerebral Lesions in Quantitative Embolic Protection Study Endpoints May Obscure Clinical Relevance

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content